91
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Chemical Composition and In Vitro Efficacy of Essential Oil of Seven Artemisia Species Against ESBL Producing Multidrug-Resistant Escherichia coli

, , , , &
Pages 124-145 | Received 21 Jul 2013, Accepted 19 Feb 2014, Published online: 16 Apr 2015
 

Abstract

Chemical composition and antibacterial and antibiotic interacting activities of essential oils obtained from the flowering branchlets of seven Artemisia species grown in Iran were investigated. Antibacterial activity against multi-drug resistance extended-spectrum β-lactamase (ESBL) positive Escherichia coli was also investigated. Major compounds in different Artemisia oils were α-phellandrene in A. absinthium, camphor in A. annua, 1,8-cineol and borneol in A. kulbadica, β-thujone in A. persica, cis-verbenol in A. santolina and 1-phenyl-penta-2,4-diene in A. scoparia. Artemisia oils showed synergism with antibiotics, in particular ciprofloxacin and nitrofurantoin, against all 5 tested ESBL positive E. coli. A. santolina and A. kulbadica showed promising synergistic activity with antibiotics. Using bioautography, compounds such as cis-verbenol, trans-verbenol and ρ-cymene-8-ol were identified as active compounds of A. santolina, and β-pinene, 1,8-cineol and borneol as active components of A. kulbadica. Artemisia species have antibacterial activity against all tested resistant ESBL positive E. coli and potentiate the efficacy of antibiotics.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.